DNA Athletic and Talent Tests for Kids: A Skeptical Look

A category of consumer DNA test marketed at parents promises to read a child’s “athletic potential” or “talent profile” from a cheek swab. The sales argument is intuitive. Pick the right sport early, save money on the wrong sports, channel a child toward the activity they are built for. We understand the appeal. We also think the science behind the pitch is much weaker than the marketing implies, and we think the downside, when the buyer is a parent making decisions about a child, is large enough to flag this category clearly.

What the tests are actually reading

Most commercial athletic DNA tests look at a small panel of variants. Two get the most attention.

ACTN3 R577X is the variant most often called “the sprint gene.” It sits in the ACTN3 gene, which codes for a structural protein in fast-twitch muscle fibers. People with the X/X genotype are deficient in alpha-actinin-3. There is a documented, replicated association between the R allele and elite sprint or power performance. A 2013 meta-analysis in the European Journal of Human Genetics pooled data across populations and confirmed the association is real.

ACE I/D is the other variant routinely cited. The deletion allele has been associated with power-based performance and the insertion allele with endurance, with mixed replication across studies.

These are real findings. The question is what they mean for the parent of a 9-year-old.

How much variance these variants actually explain

The honest accounting is small. The Webborn et al. consensus statement, published in the British Journal of Sports Medicine in 2015, brought together genetics and sports-medicine researchers from the IOC, multiple national sports institutes, and academic groups. It reached an unambiguous conclusion. Genetic tests have no role to play in talent identification or athlete development.

The reasoning, summarized from the consensus statement and the broader literature. Elite athletic performance is polygenic. Hundreds of variants contribute, each with a small effect, and known variants together explain only a small fraction of the variance in performance. Environment, training load, coaching, injury history, motivation, and biomechanics dominate. Identical-twin studies put the heritability of elite-level athletic performance in a wide range, but no responsible reading of that literature supports using a small SNP panel to direct a child’s sport.

The ACSM’s published position stands on athletic development emphasize sport-sampling, age-appropriate training, and avoiding early specialization. They do not endorse genotyping as a talent-identification tool. The Webborn paper is the document we send people to when they want a single citation.

The harm of the “for kids” framing

The reason we treat athletic DNA tests differently from, say, wine preference tests is that the decisions parents make about children’s sports are durable. Quitting a sport at 9 because a test says the child is not built for it is the kind of choice that closes doors. Pushing a child toward a sport because a test predicts power-based performance can produce injuries, burnout, or simply misery in a child who would rather be doing something else.

A test that explains a few percent of variance in performance is not a talent identifier. It is a coin flip with marketing.

It is worth noting that the FTC’s Health Products Compliance Guidance applies to performance claims as well as disease claims, and the agency has historically scrutinized direct-to-consumer genetic marketing for unsupported predictive claims.

What the science does support

It is worth saying what genetics can do here, fairly. Researchers studying elite athletes have learned a great deal about the genetics of cardiac adaptation, muscle fiber composition, injury susceptibility (the COL5A1 variants and tendon injury risk are an example), and certain rare cardiac conditions where screening is genuinely important. None of that translates to a consumer test that tells a parent which sport their child should play.

Pre-participation cardiac screening for inherited cardiomyopathies is a real medical use of genetics in sport, and it is run by clinicians, not by direct-to-consumer kits.

What to do instead

Let children try several sports. The sports-development literature is clear that early diversification, not early specialization, predicts long-term athletic development and reduces injury. A child’s enjoyment and engagement predict whether they keep playing more reliably than any genotype panel.

If you are curious about the genetics of athletic performance as a topic, read it as you would any popular-science subject. Just do not buy a prescription from it.

For other novelty categories, see our overall buyer beware piece, the diet tests explainer, and the skincare tests piece. For an actual buying guide to consumer DNA tests, our main guide and our accuracy explainer are the right starting points, along with the buying mistakes article. For a real medical question raised by any test, the NSGC genetic counselor directory is the right route.